User:hannahpjc395715

Datopotamab Deruxtecan, often abbreviated as DATO, represents the significant advancement regarding targeted cancer care. This novel antibody-drug conjugate joins a monoclonal antigen

https://www.targetmol.com/compound/datopotamab